These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 25504931)

  • 1. Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice.
    Davison LM; Jørgensen TN
    Arthritis Rheumatol; 2015 Apr; 67(4):1012-22. PubMed ID: 25504931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting mechanisms of interferon-α inhibition by intravenous immunoglobulin after induction by immune complexes versus Toll-like receptor agonists.
    Wiedeman AE; Santer DM; Yan W; Miescher S; Käsermann F; Elkon KB
    Arthritis Rheum; 2013 Oct; 65(10):2713-23. PubMed ID: 23840006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited Effect of Indolamine 2,3-Dioxygenase Expression and Enzymatic Activity on Lupus-Like Disease in B6.Nba2 Mice.
    Davison LM; Liu JC; Huang L; Carroll TM; Mellor AL; Jørgensen TN
    Front Immunol; 2019; 10():2017. PubMed ID: 31555267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 antagonists kill plasmacytoid dendritic cells from lupus-prone mice and dampen interferon-α production.
    Zhan Y; Carrington EM; Ko HJ; Vikstrom IB; Oon S; Zhang JG; Vremec D; Brady JL; Bouillet P; Wu L; Huang DC; Wicks IP; Morand EF; Strasser A; Lew AM
    Arthritis Rheumatol; 2015 Mar; 67(3):797-808. PubMed ID: 25418983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and functional alterations of pDCs in lupus-prone mice.
    Zhou Z; Ma J; Xiao C; Han X; Qiu R; Wang Y; Zhou Y; Wu L; Huang X; Shen N
    Sci Rep; 2016 Feb; 6():20373. PubMed ID: 26879679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
    Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
    Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice.
    Jørgensen TN; Roper E; Thurman JM; Marrack P; Kotzin BL
    Genes Immun; 2007 Dec; 8(8):653-62. PubMed ID: 17882225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner.
    Liu Z; Bethunaickan R; Huang W; Lodhi U; Solano I; Madaio MP; Davidson A
    Arthritis Rheum; 2011 Jan; 63(1):219-29. PubMed ID: 20954185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
    Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
    Jørgensen TN; Thurman J; Izui S; Falta MT; Metzger TE; Flannery SA; Kappler J; Marrack P; Kotzin BL
    Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Khoryati L; Augusto JF; Shipley E; Contin-Bordes C; Douchet I; Mitrovic S; Truchetet ME; Lazaro E; Duffau P; Couzi L; Jacquemin C; Barnetche T; Vacher P; Schaeverbeke T; Blanco P; Richez C;
    Arthritis Rheumatol; 2016 Sep; 68(9):2221-31. PubMed ID: 26991804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of SigH+ pDCs in B6.Nba2 mice prevents lupus-like disease development only if started before disease is fully established.
    Campbell NO; Davison LM; Banerjee S; Nguyen JK; Krafcik S; Silverman RH; Jorgensen TN
    Lupus; 2022 Nov; 31(13):1619-1629. PubMed ID: 36134524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent.
    Keller EJ; Dvorina N; Jørgensen TN
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B lymphocytes enhance interferon-α production by plasmacytoid dendritic cells.
    Berggren O; Hagberg N; Weber G; Alm GV; Rönnblom L; Eloranta ML
    Arthritis Rheum; 2012 Oct; 64(10):3409-19. PubMed ID: 22736048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.
    Zhang X; Lindwall E; Gauthier C; Lyman J; Spencer N; Alarakhia A; Fraser A; Ing S; Chen M; Webb-Detiege T; Zakem J; Davis W; Choi YS; Quinet R
    Lupus; 2015 Aug; 24(9):909-17. PubMed ID: 25654980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dichotomous effects of complete versus partial class II major histocompatibility complex deficiency on circulating autoantibody levels in autoimmune-prone mice.
    Stohl W; Xu D; Metzger TE; Kim KS; Morel L; Kotzin BL
    Arthritis Rheum; 2004 Jul; 50(7):2227-39. PubMed ID: 15248222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-interferon alpha treatment in SLE.
    Kirou KA; Gkrouzman E
    Clin Immunol; 2013 Sep; 148(3):303-12. PubMed ID: 23566912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siglec-H
    Ahodantin J; Wu J; Funaki M; Flores J; Wang X; Zheng P; Liu Y; Su L
    Cell Mol Gastroenterol Hepatol; 2024; 18(3):101367. PubMed ID: 38849082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.